VKTX Stock Loses Over $1B in a Month: How to Play the Stock?

Shares of Viking Therapeutics (VKTX) have lost nearly 17% in the past month, translating to about $1.2 billion in market value, compared with the industry’s 7.1% decline. The stock has also underperformed the sector and the S&P 500 during the same period, as shown in the chart below. VKTX’s shares are trading below the 50 and 200-day moving averages.VKTX Stock Underperforms Industry, Sector & S&P 500 Image Source: Zacks Investment ResearchThough this biotech’s progress with its obesity drug program has been ...